Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG

---

Publications & Presentations

56. Johnson P N, Shaddix B P, Weller B M, Oschman A, George D, Neely S, Miller J L. Exploring Residency Program Directors, Preceptors, and Residents' Intentions to Participate in Multicenter Pediatric Pharmacy Resident Research Projects. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2021; 26 : 708-717

57. Miller J L, Lewis T V, Walling J, O'Donnell A, Neely S, Johnson P N. Publication Rates of Pediatric-Focused Resident Research Projects Presented at The Pediatric Pharmacy Association Bruce Parks Memorial Residency Showcase. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2021; 26 : 163-171

58. Bradford C V, Cober M P, Miller J L. Refeeding Syndrome in the Neonatal Intensive Care Unit. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2021; 26 : 771-782

59. Zander E, Hintze T D, Sallee B, Allen P, Miller J L, Sagdeo M. Treatment of Toxic Epidermal Necrolysis with Etanercept in a Pediatric Patient. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2021; 26 : 758-761

60. Boucher E A, Burke M M, Klein K C, Miller J L. Update to the Minimum Requirements for Core Competency in Pediatric Hospital Pharmacy Practice. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2021; 26 : 762-766

Grants

1. Selenium Pharmacokinetics and Pharmacodynamics of Infants with Intestinal Failure a Prospective Cohort Study. Misc Non-Federal. Start Date: 2025. End Date: 2026.

2. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

3. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

5. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

Awards and Honors

1. Pediatric Pharmacy Association. Outstanding Original Research Award. Date: 2026.


2. University of Oklahoma College of Pharmacy Alumni Association. Ralph D. Bienfang Outstanding Practitioner Award. Date: 2025.


3. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2025.


4. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2024.


5. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2024.

Education

1. Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.


2. Degree: BS. Trevecca Nazarene University. Date: 2002.

Administrative Assignments

1. Role: Department Vice-Chair. Scope: Department. Date: 2021.
Read More